Dolutegravir 50mg + Emtricitabine 200mg + TAF 25mg | Brand: Odefsey
Houston has one of Texas's largest HIV-positive populations, making access to effective and affordable antiretroviral therapy a public health priority across the city's extensive community health network. Spegra, the Indian WHO-GMP certified generic of Odefsey, offers a complete HIV-1 treatment regimen in a single daily tablet at significantly reduced cost compared to branded alternatives.
Spegra combines Dolutegravir 50mg — a next-generation integrase strand transfer inhibitor with a high barrier to resistance — with Emtricitabine 200mg and Tenofovir Alafenamide 25mg. This triple-drug combination is WHO-recommended as a preferred first-line HIV regimen worldwide, valued for its rapid viral suppression, excellent tolerability, and near-zero resistance development rates in treatment-naive patients.
The TAF component in Spegra provides superior renal and bone safety compared to older TDF-based regimens, important for Houston's ageing HIV-positive population and patients with kidney conditions. For Houston's significant uninsured community, generic Spegra makes this gold-standard regimen financially accessible. Visit medshopy.com or WhatsApp +91 82650 41513.
Spegra combines Dolutegravir 50mg — a next-generation integrase strand transfer inhibitor with a high barrier to resistance — with Emtricitabine 200mg and Tenofovir Alafenamide 25mg. This triple-drug combination is WHO-recommended as a preferred first-line HIV regimen worldwide, valued for its rapid viral suppression, excellent tolerability, and near-zero resistance development rates in treatment-naive patients.
The TAF component in Spegra provides superior renal and bone safety compared to older TDF-based regimens, important for Houston's ageing HIV-positive population and patients with kidney conditions. For Houston's significant uninsured community, generic Spegra makes this gold-standard regimen financially accessible. Visit medshopy.com or WhatsApp +91 82650 41513.
